Rosenson RS - Search Results

1

Inhibition of proinflammatory cytokine production by pravastatin.

Rosenson RS, Tangney CC, Casey LC. Rosenson RS, et al. Lancet. 1999 Mar 20;353(9157):983-4. doi: 10.1016/S0140-6736(98)05917-0. Lancet. 1999. PMID: 10459915 No abstract available.

2

Statins reduce oxidized low-density lipoprotein levels, but do not alter soluble intercellular cell-adhesion molecule-1 and vascular cell-adhesion molecule-1 levels in subjects with hypercholesterolaemia.

Rosenson RS, Wolff D, Tangney CC. Rosenson RS, et al. Clin Sci (Lond). 2004 Feb;106(2):215-7. doi: 10.1042/CS20030291. Clin Sci (Lond). 2004. PMID: 12967321 Clinical Trial.

3

Beneficial effects of statins.

Rosenson RS, Tangney CC. Rosenson RS, et al. Lancet. 1996 Dec 7;348(9041):1583. doi: 10.1016/S0140-6736(05)66194-6. Lancet. 1996. PMID: 8950893 No abstract available.

4

Association between reduced low density lipoprotein oxidation and inhibition of monocyte chemoattractant protein-1 production in statin-treated subjects.

Rosenson RS, Tangney CC, Levine DM, Parker TS, Gordon BR. Rosenson RS, et al. J Lab Clin Med. 2005 Feb;145(2):83-7. doi: 10.1016/j.lab.2004.11.012. J Lab Clin Med. 2005. PMID: 15746650 Clinical Trial.

5

Comparative study of HMG-CoA reductase inhibitors on fibrinogen.

Rosenson RS, Tangney CC, Schaefer EJ. Rosenson RS, et al. Atherosclerosis. 2001 Apr;155(2):463-6. doi: 10.1016/s0021-9150(00)00590-6. Atherosclerosis. 2001. PMID: 11254918 Clinical Trial.

6

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.

Rosenson RS, Tangney CC. Rosenson RS, et al. JAMA. 1998 May 27;279(20):1643-50. doi: 10.1001/jama.279.20.1643. JAMA. 1998. PMID: 9613915 Review.

7

Elevated soluble tumor necrosis factor receptor levels in non-obese adults with the atherogenic dyslipoproteinemia.

Rosenson RS, Tangney CC, Levine DM, Parker TS, Gordon BR. Rosenson RS, et al. Atherosclerosis. 2004 Nov;177(1):77-81. doi: 10.1016/j.atherosclerosis.2004.05.027. Atherosclerosis. 2004. PMID: 15488868 Clinical Trial.

8

Short-term reduction in bone markers with high-dose simvastatin.

Rosenson RS, Tangney CC, Langman CB, Parker TS, Levine DM, Gordon BR. Rosenson RS, et al. Osteoporos Int. 2005 Oct;16(10):1272-6. doi: 10.1007/s00198-005-1897-1. Epub 2005 Aug 9. Osteoporos Int. 2005. PMID: 16088363 Clinical Trial.

9

Effects of tourniquet application on plasma viscosity measurements.

Rosenson RS, Tangney CC. Rosenson RS, et al. Clin Hemorheol Microcirc. 1998 Jul;18(2-3):191-4. Clin Hemorheol Microcirc. 1998. PMID: 9699041

10

Intraindividual variability in plasma viscosity measurements.

Rosenson RS, Tangney C. Rosenson RS, et al. Thromb Haemost. 1998 May;79(5):1063-4. Thromb Haemost. 1998. PMID: 9609253 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

428 results

Search Page